Cyclodextrins in new therapeutic systems;Ciclodextrinas em novos sistemas terapêuticos

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 37, Issue 1, 2001, Pages 1-17

  Saltao R ^a   Veiga, F ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cyclodextrins; Liposomes; Microparticles; Nanoparticles

Indexed keywords

CYCLODEXTRIN; LIPOSOME; NANOPARTICLE;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; REVIEW; TECHNOLOGY;

EID: 0035157486     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Bioadesive potential of gliadin nanoparticulate systems
2. Interaction of NSA with cyclodextrins and hydroxipropyl cyclodextrin derivatives
3. Improvement of the in vitro dissolution of praziquantel by complexation with αβ and -γ-cyclodextrins
4. Preparation and characterisation of β-cyclodextrin and poly(acrylic acid) microspheres
5. Investigations into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres
6. Poly(acrylic acid) microspheres containing β-cyclodextrin: Loading and in vitro release of two dyes
7. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems
8. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins
9. Comparative study of the association of itraconazole with colloidal drug carriers
10. Vecteurs nanoparticulaires de médicaments
11. Long acting injectable oxitetracycline-lipospher formulations
12. Amphiphilic cyclodextrins and targeting of drugs
13. Cyclodextrins in targeting application to nanoparticles
14. Cyclodextrins and carrier systems
15. Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes
16. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxipropil-β-cyclodextrin inclusion complexes
17. Fate of injected liposomes: Observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo
18. Phase-solubility techniques
19. Cyclodextrin-based controlled drug release system
20. Preparation of microspheres of water-soluble pharmaceuticals
21. Pharmaceutical applications of cyclodextrins III toxicological issues and safety evaluation
22. Release profiles of a hydrophobic drug incorporated in modified cyclodextrin nanospheres
23. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading
24. Evaluation of hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrin nanospheres
25. Cyclodextrin complexation of NSAIDs: Physicochemical characteristics
26. Pharmaceutical applications of cyclodextrins. 1 Drug solubilization and stabilization
27. Cyclodextrins in pharmaceutical formulations. The effects of polymers on their complexation efficacy drug availability
28. Novel liposome based multicomponent systems for the protection of photolabile agents
29. Drugs in cyclodextrins in liposomes: A novel approach to the chemical stability of drugs sensitive to hydrolysis
30. Steric stabilization of nanoparticles: Size and surface properties
31. Kinetic difference between hydrolyses of γ-ciclodextrin by human salivary and pancreatic-α-amylases
32. Drugs in cyclodextrins in liposomes: A novel concept in drug delivery
33. Drugs in cyclodextrins in liposomes: An approach to controlling the fate of water insoluble drugs in vivo
34. Physicochemical properties and inclusion complex formation of δ-cyclodextrin
35. Combined poly (isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs
36. Influence of solubility and partition coefficient on the loading of combined poly(isobutylcyanoacrylate) and hydroxypropyl-β-cyclodextrin nanoparticles by steroids
37. Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
38. Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrin
39. Preparation of microspheres by the solvent evaporation technique
40. Vecteurs micro et nanoparticulaires
41. NSAID Gastropathy. Novel physicochemical approaches for reducing gastric mucosal injury by drug complexation with cyclodextrins
42. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery
43. Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules
44. Biosynthesis of cycloglycosyltransferase and obtention of its enzimatic reaction products
45. Encapsulation and release of Rhodium (II) citrate and its association complex with hydroxipropyl-β-cyclodextrin from biodegradable polymer microspheres
46. Cyclodextrins
47. Cyclodextrins: Properties and applications
48. Cyclodextrins
49. Development of a new colloidal drug carrier from chemically-modified cyclodextrins: Nanospheres and influence of physicochemical and technological factors on particle size
50. Characterization of amphiphilic β-cyclodextrin nanospheres
51. Spontaneous formation of drug containing amphiphilic β-cyclodextrin nanocapsules
52. Solubilization and interaction of sulindac with β-cyclodextrin in solid state and in aqueous solution
53. Cyclodextrins in drug carrier systems
54. New perspectives in cyclodextrin pharmaceutical applications cyclodextrin derivatives as new drug carriers
55. Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl-α-cyclodextrin
56. Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes
57. Formulation of triancinolone acetonide pellets suitable for coating and colon targeting
58. A new concept in drug delivery based on "skirt-shaped cyclodextrin aggregates". Present state and future prospects
59. Biopharmaceutical evaluation of maltosyl-β-cyclodextrin as a parenteral drug carrier
60. The controlled delivery of drugs to the lung
61. Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face